Summary: Researchers identified 11 independent genomic risk regions (loci) and 9 specific candidate genes linked to BPD development. The study establishes that common genetic variants account for 17.3% of the disorder’s liability, proving that BPD shares a highly polygenic architecture with other major psychiatric conditions.
The analysis revealed strong genetic overlaps with post-traumatic stress disorder (PTSD), major depression, ADHD, antisocial behavior, and self-harm, alongside physical health conditions like COPD and type 2 diabetes, offering a biological foundation for transdiagnostic clinical care.
Key Facts
- First Large-Scale Mapping: The study identified 11 independent genomic loci and 9 distinct candidate genes associated with susceptibility to borderline personality disorder.
- Heritability & Polygenic Risk: Common single-nucleotide polymorphisms (SNPs) account for 17.3% of BPD liability, yielding a polygenic score (PGS) predictive power of 4.6%.
- Psychiatric & Physical Overlaps: Strong genetic correlations were uncovered between BPD and PTSD, major depressive disorder, ADHD, antisocial behavior, suicidal/self-injurious behaviors, as well as physical conditions including COPD and diabetes.
- Parallels to Schizophrenia Trajectory: Senior researchers note that these initial 11 loci parallel the early schizophrenia GWAS findings from 15 years ago, predicting an exponential increase in gene discovery as global cohort sizes expand and diversify.
- Open Data for Drug Discovery: The full summary statistics are being made publicly available to accelerate follow-up functional studies and inform drug development—noting that therapeutics with genetic validation are significantly more likely to succeed in clinical trials.
Source: CIMH
An international team led by the Central Institute of Mental Health in Mannheim has presented the largest genome-wide association study on borderline personality disorder to date. Data from about 13,000 affected people and more than 1.1 million controls from 14 countries were analyzed.
The study identified 11 independent risk regions and nine genes that could contribute to the development of the disorder.
The findings, published in Nature Genetics, show clear genetic overlaps with other mental and physical illnesses and open new perspectives for research and care.
Borderline personality disorder (BPD) is a severe mental illness characterized by emotional instability, impulsive behavior, a disturbed self-image and considerable difficulties in interpersonal relationships. It often begins in adolescence and affects around 0.9%–1.9% of the population in Western countries—with significantly higher diagnosis rates among women.
Many affected people show self-harming behavior, suicidal thoughts or repeated suicide attempts. Despite the high psychological burden, frequent coexisting illnesses and lack of specific medication, the biological causes are still poorly understood.
11 risk regions and nine candidate genes
An international research team led by the Central Institute of Mental Health (CIMH) in Mannheim, Germany, has now conducted the largest genome-wide association study (GWAS) on borderline personality disorder to date. The analysis includes genetic data from around 13,000 affected people and more than 1.1 million controls from 14 countries. The aim was to identify genetic risk factors for the disorder and better understand which biological mechanisms play a role.
The scientists analyzed millions of genetic variants (so-called SNPs) in the participants’ genetic material and identified 11 independent genomic regions (loci) associated with an increased risk of BPD. Further analyses also identified nine specific genes that may directly contribute to the development of the disorder.
Genetic proportion and predictive power
The proportion of susceptibility to the disorder attributable to the genetic factors studied was estimated at 17.3%. Using a polygenic score (PGS) based on the results, the individual risk of developing the disorder was predicted to be 4.6% on the same scale.
“In our analysis, we were able to identify several new risk genes for BPD—an important step toward a deeper understanding of the genetic architecture of this complex disease. The results clearly show that borderline personality disorder, like other mental illnesses, has a polygenic basis,” says Dr. Stephanie Witt, assistant head of the Department of Genetic Epidemiology in Psychiatry at the CIMH and last author of the study.
Broad overlap with other diseases
The study also shows that genetic risk factors for BPD have significant overlaps with other mental and physical illnesses. Particularly strong genetic similarities were found with post-traumatic stress disorder (PTSD), depression, ADHD, antisocial behavior, as well as suicidal and self-injurious behavior. Genetic overlaps were also found with physical illnesses such as chronic obstructive pulmonary disease (COPD) and diabetes.
These findings underscore that borderline personality disorder is a highly complex, polygenic disorder whose genetic basis is linked to other psychiatric and physical diseases. “Borderline personality disorder is one of the most serious mental illnesses—and yet we know surprisingly little about its biological basis.
“Our study shows for the first time at a genetic level that BPD is associated with a variety of other psychiatric and physical illnesses. This opens up new ways to better understand the causes and, in the long term, improve the care of those affected,” says Dr. Fabian Streit, a member of the Hector Institute for Artificial Intelligence in Psychiatry (HITKIP) at the CIMH and lead author of the study.
“These findings highlight the highly polygenic nature of borderline personality disorder. They resemble the early schizophrenia GWAS results around 15 years ago, which initially identified only a few risk loci—before international collaborations and ever-larger cohorts led to an exponential growth of discoveries. A similar trajectory can be expected for borderline. It will therefore be crucial to extend studies to more diverse ancestry groups and to integrate genetic findings with clinical phenotypes and environmental exposures, such as trauma.
“Only through such efforts can we disentangle the underlying mechanisms and ultimately inform the development of targeted therapeutic strategies,” says Prof. Dr. Stephan Ripke, head of the Laboratory for Statistical Genetics at the Department of Psychiatry and Psychotherapy at Charité—Universitätsmedizin Berlin and last author of the study.
Prof. Dr. Christian Schmahl, medical director of the Clinic for Psychosomatics and Psychotherapeutic Medicine at the CIMH, adds, “The new study provides important impetus for a better understanding of the biological causes and resulting treatment options. The results fit very well with our increasingly transdiagnostic approach and underscore that we tailor our treatment plans to comorbidities.”
Large data sets and more diverse ancestry
The research team sees considerable potential in additional, larger data sets and the inclusion of diverse ancestry groups. More differentiated phenotyping and dynamic omics measures, such as epigenomic and transcriptomic measures, should also help better understand genetic risks in combination with environmental influences such as traumatic experiences.
The researchers are making their results available to the scientific community. The data should facilitate follow-up work and benefit patients in the long term. Studies show that drugs with genetic support are more likely to be successful in clinical trials.
Key Questions Answered:
A: Historically, BPD was often viewed primarily through a psychological or environmental lens, with limited understanding of its underlying biological mechanisms. This study provides the first definitive, large-scale genomic proof that BPD has a clear polygenic basis, similar to schizophrenia and major depression, identifying 11 specific risk loci and 9 candidate genes for the first time.
A: The study revealed significant genetic correlation between BPD and other conditions like PTSD, depression, ADHD, and self-harm, as well as physical conditions like COPD and diabetes. This indicates that shared, overlapping biological pathways predispose individuals to multiple psychiatric and somatic conditions simultaneously, supporting a transdiagnostic approach to treatment.
A: Early schizophrenia GWAS initially identified only a handful of risk loci before expanding into hundreds as international sample sizes grew. Researchers expect BPD genetic discovery to follow the exact same exponential path as future studies incorporate larger, more diverse global cohorts and integrate genetic data with environmental factors like childhood trauma.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this BPD and genetics research news
Author: Torsten Lauer
Source: CIMH
Contact: Torsten Lauer – CIMH
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Genome-wide association analyses of borderline personality disorder identify 11 loci and highlight shared risk with mental and somatic disorders” by Fabian Streit, Swapnil Awasthi, Alisha S. M. Hall, Alice Braun, Maria Niarchou, Eirini Marouli, Oladapo Babajide, Josef Frank, Lea Zillich, Carolin M. Callies, Diana Avetyan, Eric Zillich, Joonas Naamanka, Jean Gonzalez, Arvid Harder, Yi Lu, Zouhair Aherrahrou, Zain-Ul-Abideen Ahmad, Helga Ask, Anthony Batzler, Michael E. Benros, Odette M. Brand-de Wilde, Søren Brunak, Mie T. Bruun, Lea A. N. Christoffersen, Lucía Colodro-Conde, Brandon J. Coombes, Elizabeth C. Corfield, Norbert Dahmen, Maria Didriksen, Khoa M. Dinh, Srdjan Djurovic, Joseph Dowsett, Ole Kristian Drange, Helene Dukal, Susanne Edelmann, Christian Erikstrup, Mariana K. Espinola, Eva Fassbinder, Annika Faucon, Diana S. Ferreira de Sá, Jerome C. Foo, Maria Gilles, Alfonso Gutiérrez-Zotes, Thomas F. Hansen, Magnus Haraldsson, R. Patrick Harper, Alexandra Havdahl, Urs Heilbronner, Stefan Herms, Henrik Hjalgrim, Christopher Hübel, Gitta A. Jacob, Bitten Aagaard, Anders Jorgensen, Martin Jungkunz, Nikolaus Kleindienst, Nora Knoblich, Stefanie Koglin, Julia Kraft, Kristi Krebs, Christopher W. Lee, Yuhao Lin, Stefanie Lis, Amanda Lisoway, Ioannis A. Malogiannis, Amy Martinsen, Tolou Maslahati, Katharina Merz, Andreas Meyer-Lindenberg, Susan Mikkelsen, Christina Mikkelsen, Arian Mobascher, Gerard Muntané, Asmundur Oddsson, Sisse R. Ostrowski, Teemu Palviainen, Ole B. V. Pedersen, Geir Pedersen, Liam Quinn, Matthias A. Reinhard, Florian A. Ruths, Björn H. Schott, Michael Schredl, Emanuel Schwarz, Cornelia E. Schwarze, Michael Schwinn, Tabea Sarah Send, Engilbert Sigurdsson, Katja Simon-Keller, Astros T. Skuladottir, Joaquim Soler, Anne Sonley, Erik Sørensen, Hreinn Stefansson, Peter Straub, Jaana Suvisaari, Martin Tesli, Jacob Træholt, Henrik Ullum, Maja P. Völker, G. Bragi Walters, Rujia Wang, Christian C. Witt, Gerhard Zarbock, Peter Zill, John-Anker Zwart, DBDS Genomic Consortium, the GLAD Study, HUNT All-In Psychiatry, Ole A. Andreassen, Arnoud Arntz, Joanna M. Biernacka, Martin Bohus, Gerome Breen, Alexander L. Chapman, Sven Cichon, Lea K. Davis, Michael Deuschle, Sebastian Euler, Sabine C. Herpertz, Benjamin Hummelen, Andrea Jobst, Jaakko Kaprio, James L. Kennedy, Kelli Lehto, Klaus Lieb, Lourdes Martorell, Shelley McMain, Richard Musil, Vanessa Nieratschker, Markus M. Nöthen, Frank Padberg, Aarno Palotie, Juan C. Pascual, Nader Perroud, Josep A. Ramos-Quiroga, Ted Reichborn-Kjennerud, Marta Ribases, Stefan Roepke, Dan Rujescu, Sandra Sanchez-Roige, Claudia Schilling, Christian Schmahl, Kari Stefansson, Thorgeir E. Thorgeirsson, Gustavo Turecki, Elisabet Vilella, Thomas Werge, Bendik S. Winsvold, Johannes Wrege, Marcella Rietschel, Stephan Ripke & Stephanie H. Witt. Nature Genetics
DOI:10.1038/s41588-026-02654-3
Abstract
Genome-wide association analyses of borderline personality disorder identify 11 loci and highlight shared risk with mental and somatic disorders
Borderline personality disorder (BPD) is a severe mental health condition influenced by environmental risk factors (for example, interpersonal trauma) and genetic factors.
We conducted the largest genome-wide association study (GWAS) meta-analysis of BPD so far, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls (all participants of European ancestry).
We identified 11 independent associated genomic loci and 9 risk genes in gene-based analyses. We observed a single-nucleotide polymorphism heritability of 17.3% and derived polygenic scores (PGS) that predicted 4.6% of the phenotypic variance in BPD on the liability scale.
BPD showed the strongest positive genetic correlations with GWAS of post-traumatic stress disorder, depression, attention deficit hyperactivity disorder, antisocial behavior, and measures of suicide and self-harm.
Phenome-wide analyses in Vanderbilt University Medical Center Biobank and UK Biobank using BPD-PGS confirmed these associations and also identified associations with other medical conditions, including obstructive pulmonary disease and diabetes.
These analyses highlight BPD as a polygenic disorder, with the genetic risk showing substantial overlap with psychiatric and physical health conditions.
